The Audioconference agenda is set forth in Eastern Daylight Time below:
|
|
1:00 pm |
Welcome and Introductory Remarks
Arnold I. Friede, Esq. (Moderator)
|
|
1:05 pm |
Analysis of the Key Features of Eli Lilly's Zyprexa Settlement
James D. Kole, Esq.
|
|
1:20 pm |
Analysis of the Key Features of Pfizer's Bextra Settlement
David Hart, Esq.
|
|
1:35 pm |
How the Zyprexa and Bextra Settlements are Filling a Void in FDA Guidance Regarding Medical Reprints, Off-label Promotion, and Drug Marketing
Meredith Manning, Esq.
|
|
1:50 pm |
Observations of an Industry Attorney: How Will the Zyprexa and Bextra Settlements Impact Free Drug Samples and Continuing Medical Education
Arnold I. Friede, Esq.
|
|
2:00 pm |
Questions and Answers
Arnold I. Friede, Esq. (Moderator)
|
|
2:30 pm |
Audioconference Adjournment
|
